“I refuse to call it a vaccine because it doesn’t meet any of the standards by which a vaccine is supposed to work: to prevent the spread of infection, to keep you from getting sick, to keep you from being hospitalized, to decrease the amount of illness, to protect people from this contagion that’s out there. It doesn’t meet any of those standards.”
Nepute added that whilst there are normally “17 points of criteria” to be met before giving emergency use authorization (EUA) to a vaccine, the current vaccines “came nowhere near close to doing that,” yet were still given EUA.
Genetic study suggests that people’s blood type may affect their COVID-19 risk
People with type A blood may have higher risk of severe illness, while those with type O may have lower risk
by Alla Katsnelson, special to C&EN
“When a medical product is being used under an EUA, it is an authorized (though not an approved or cleared) medical product for use in clinical care that has met statutory criteria under section 564 of the [Federal Food, Drug, and Cosmetic Act] FD&C Act,” FDA writes.
No one knows what levels of neutralizing antibodies are needed to protect from SARS-CoV-2 infection, explains Dennis Burton, an immunologist at Scripps Research, but the levels induced by CanSino’s vaccine “are not overwhelming by any means at all.”
It is not great, but it is better than nothing.
Hildegund C.J. Ertl, adenoviral vector vaccine scientist, the Wistar Institute
“It is not great, but it is better than nothing,” says Hildegund C.J. Ertl, a scientist who develops and studies adenoviral vector vaccines at the Wistar Institute in Philadelphia. She says the antibody responses are “a little disappointing,” particularly in the oldest participants in the study, aged 45-60, who were less likely to develop neutralizing antibodies.
“I refuse to call it a vaccine because it doesn’t meet any of the standards by which a vaccine is supposed to work: to prevent the spread of infection, to keep you from getting sick, to keep you from being hospitalized, to decrease the amount of illness, to protect people from this contagion that’s out there. It doesn’t meet any of those standards.”
But normies recognise the term "vaccine" so call it "experimental vaccine" and they'll understand ithe concept.
https://www.lifesitenews.com/news/doctors-expose-untested-covid-vaccines-warn-of-cascade-of-harmful-effects-and-deaths
Nepute added that whilst there are normally “17 points of criteria” to be met before giving emergency use authorization (EUA) to a vaccine, the current vaccines “came nowhere near close to doing that,” yet were still given EUA.
COVID injection has not met the Emergency Use Authorization!!!
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states
https://www.federalregister.gov/documents/2020/04/01/2020-06905/emergency-use-authorization-declaration
Changes made in fed register
You are doing a fantastic set of posts on the "vaccine". Thank you!
I said the same thing a few days ago. My current label is "murderer" until I'm re "woke" these people ate truly sick.
Genetic study suggests that people’s blood type may affect their COVID-19 risk People with type A blood may have higher risk of severe illness, while those with type O may have lower risk by Alla Katsnelson, special to C&EN
JUNE 11, 2020 | APPEARED IN VOLUME 98, ISSUE 23
https://cen.acs.org/biological-chemistry/infectious-disease/Genetic-study-suggests-peoples-blood/98/i23?utm_source=mostread&utm_medium=mostread&utm_campaign=CEN
You're absolutely correct. HCQ does that, and they couldn't allow that to happen.
“When a medical product is being used under an EUA, it is an authorized (though not an approved or cleared) medical product for use in clinical care that has met statutory criteria under section 564 of the [Federal Food, Drug, and Cosmetic Act] FD&C Act,” FDA writes.
https://www.raps.org/news-and-articles/news-articles/2021/1/fda-exclusion-not-necessary-for-eua-vaccine-therap
No one knows what levels of neutralizing antibodies are needed to protect from SARS-CoV-2 infection, explains Dennis Burton, an immunologist at Scripps Research, but the levels induced by CanSino’s vaccine “are not overwhelming by any means at all.”
It is not great, but it is better than nothing. Hildegund C.J. Ertl, adenoviral vector vaccine scientist, the Wistar Institute
“It is not great, but it is better than nothing,” says Hildegund C.J. Ertl, a scientist who develops and studies adenoviral vector vaccines at the Wistar Institute in Philadelphia. She says the antibody responses are “a little disappointing,” particularly in the oldest participants in the study, aged 45-60, who were less likely to develop neutralizing antibodies.
https://cen.acs.org/pharmaceuticals/vaccines/CanSino-publishes-first-COVID-19/98/i21